Obsessive Compulsive Disorder: Pharmacologic Approaches

  • Thomas R. Insel
  • Edward A. Mueller


Obsessive compulsive disorder (OCD) presents in several different forms. Patients with OCD may complain primarily of intrusive thoughts (i.e. obsessions) or primarily of behavioral rituals (i.e. compulsions). While the behavioral techniques of exposure and response prevention may be very helpful to patients with rituals and particularly to those with “avoidant” behavior, there are many obsessionals for whom behavior treatment may not suffice. These include patients who will not comply with the exposure and response prevention techniques, patients with severe secondary depressions, and patients with primarily obsessional and not “avoidant” complaints. For such patients, pharmacotherapy may be essential.


Obsessive Compulsive Disorder Obsessive Compulsive Disorder Growth Hormone Response Intrusive Thought Obsessive Compulsive Disorder Patient 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    T. R. Insel, N. H. Kalin, L. B. Guttmacher, R. M. Cohen, and D. L. Murphy, The dexamethasone suppression test in patients with primary obsessive-compulsive disorder, Psychiatry Res. 6: 153 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    T. R. Insel, J. C. Gillin, A. Moore, R. Loewenstein, D. L. Murphy, and W. Mendelson, Sleep in obsessive-compulsive disorder, Arch. Gen. Psychiatry 39: 1372 (1982).PubMedCrossRefGoogle Scholar
  3. 3.
    L. Siever, T. R. Insel, D. Jimerson, C. R. Lake, T. W. Uhde, J. Aloi, and D. L. Murphy, Blunted growth hormone response to clonidine in obsessive-compulsive patients, Br. J. Psychiatry 142: 184 (1983).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Hamilton, Development of a rating scale for primary depressive illness, Br. J. Clin. Psychol. 6: 278 (1967).CrossRefGoogle Scholar
  5. 5.
    P. Thoren, M. Asberg, B. Chronholm, et al., Clomipramine treatment of obsessive compulsive disorder: A controlled clinical trial, Arch. Gen. Psychiatry 37: 1281 (1980).PubMedCrossRefGoogle Scholar
  6. 6.
    I. Marks, R. Stern, D. Mawson, et al., Clomipramine and exposure for obsessive compulsive rituals, Br. J. Psychiatry 136: 1 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    S. A. Montgomery, Clomipramine in obsessional neurosis: A placebo controlled trial, Pharm. Med. 1: 189 (1980).Google Scholar
  8. 8.
    J. Ananth, J. C. Pecknold, N. VanDer Steen, et al., Double blind comparative study of clomipramine and amitriptyline in obsessive neurosis, Prog. Neuropsychopharmacol. 5: 257 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    T. R. Insel, D. L. Murphy, R. M. Cohen, I. Alterman, C. Kilts, and M. Linnoila, Obsessive-compulsive disorder - A double-blind trial of clomipramine and clorgyline, Arch. Gen. Psychiatry 40: 605 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    R. S. Stern, I. M. Marks, J. Wright, et al., Clomipramine: plasma levels, side-effects, and outcome in obsessive compulsive neurosis, Postgrad. Med. J. 56: 134 (1980).PubMedGoogle Scholar
  11. 11.
    S. R. Ross, and A. L. Renyi, Inhibition of neuronal uptake, Neuropharmacology 16: 57 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    D. P. Benfield, C. M. Harries, and D. K. Luscombe, Some pharmacological aspects of desmethylclomipramine, Postgrad. Med. J. 56: 13 (1980).PubMedGoogle Scholar
  13. 13.
    American Psychiatric Association, Committee on Nomenclature and Statistics, Diagnostic and Statistical Manual of Mental Disorders, ed. 3, Washington, D.C., American Psychiatric Association (1980).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Thomas R. Insel
    • 1
  • Edward A. Mueller
    • 1
  1. 1.Clinical Neuropharmacology BranchNational Institute of Mental HealthBethesdaUSA

Personalised recommendations